Predisposition Biomarkers Market Poised to Surpass USD 12.4 Billion by 2035, Driven by Early Detection Technologies – FMIBlog
The global Predisposition Biomarkers Market is set for remarkable expansion, projected to grow from USD 5.6 billion in 2025 to USD 12.4 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 8.2%. This growth trajectory underscores the growing role of predictive diagnostics in transforming healthcare from reactive to proactive management, as both established and emerging players invest heavily in genomics, bioinformatics, and personalized medicine technologies.
